文献速递皮肤肿瘤

靶向H3K4去甲基化酶KDM5B重编程黑色素瘤细胞的代谢组与表型

Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells.
PubMed 文献 · J Invest Dermatol · 2019-06-21

研究通过RNAi或多西环素诱导过表达稳定调控KDM5B,用快速液相色谱-高分辨质谱分析黑色素瘤细胞代谢组。发现KDM5B依赖的代谢组中11种胞内代谢物受显著且高度特异调控;KDM5B过表达拓宽氧化代谢、上调磷酸戊糖途径并维持高还原型/氧化型谷胱甘肽比值。组蛋白赖氨酸去甲基化酶抑制剂(GSK-J1、2,4-PDCA)在三维模型中减少集落形成和侵袭。

要点

  • KDM5B过表达使黑色素瘤细胞氧化代谢从主要依赖谷氨酰胺转向兼用葡萄糖和脂肪酸。
  • KDM5B过表达上调磷酸戊糖途径以提供抗氧化NADPH,并维持高还原型/氧化型谷胱甘肽比值。
  • 组蛋白赖氨酸去甲基化酶抑制剂GSK-J1和2,4-PDCA在三维模型中减少集落形成和侵袭。

核心结论

  • 靶向KDM5B可能成为调控黑色素瘤代谢组和恶性细胞行为的替代途径。

研究设计与样本

  • 研究通过RNAi或多西环素诱导过表达稳定调控黑色素瘤细胞中KDM5B表达,并建立快速、标准化的高灵敏液相色谱-高分辨质谱方案分析代谢组。

主要发现

  • 在KDM5B依赖的代谢组中,发现11种胞内代谢物受显著且高度特异调控。
  • KDM5B过表达导致黑色素瘤细胞氧化代谢从主要依赖谷氨酰胺拓宽为兼用葡萄糖和脂肪酸。
  • KDM5B过表达上调磷酸戊糖途径作为抗氧化NADPH来源,并维持高还原型/氧化型谷胱甘肽比值。
  • 组蛋白赖氨酸去甲基化酶抑制剂GSK-J1和2,4-PDCA在三维模型中减少集落形成和侵袭。

临床怎么用

  • 靶向KDM5B或组蛋白赖氨酸去甲基化酶可能作为调控黑色素瘤代谢与恶性行为的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Melanoma cells shift between epigenetic-metabolic states to adapt to stress and, particularly, to drugs. Here, we unraveled the metabolome of an H3K4 demethylase (KDM5B/JARID1B)-driven melanoma cell phenotype that is known to be multidrug resistant. We set up a fast protocol for standardized, highly sensitive liquid chromatography-high resolution mass spectrometry analyzing stably controlled KDM5B expression by RNAi or doxycycline-induced overexpression. Within the KDM5B-dependent metabolome, we found significant and highly specific regulation of 11 intracellular metabolites. Functionally, overexpression of KDM5B in melanoma cells led to broadening of their oxidative metabolism from mainly glutamine-dependent to additionally glucose- and fatty acid-utilizing, upregulation of the pentose phosphate pathway as a source of antioxidant NADPH, and maintenance of a high ratio of reduced to oxidized glutathione. Histone lysine demethylase inhibition (GSK-J1, 2,4-PDCA) decreased colony formation and invasion in three-dimensional models. Thus, targeting KDM5B could represent an alternative way of modulating the metabolome and malignant cell behavior in melanoma.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Vogel FCE, Bordag N, Zügner E, et al. Targeting the H3K4 Demethylase KDM5B Reprograms the Metabolome and Phenotype of Melanoma Cells. J Invest Dermatol. 2019. PMID: 31229500. doi:10.1016/j.jid.2019.06.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。